Related Experiment Video
Updated: May 7, 2026

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
Published on: November 1, 2018
A small compound targeting the interaction between nonstructural proteins 2B and 3 inhibits dengue virus replication
Sabar Pambudi1, Norihito Kawashita, Supranee Phanthanawiboon
1Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan.
Researchers discovered a new small molecule, SK-12, that inhibits dengue virus (DENV) replication by blocking the essential NS2B/NS3 protease interaction. This compound shows promise as a potential antiviral therapeutic.
Area of Science:
- Virology
- Biochemistry
- Drug Discovery
Background:
- Dengue virus (DENV) polyprotein maturation relies on the NS2B/NS3 serine-protease complex.
- The NS2B cofactor is crucial for NS3 enzymatic activity; its dissociation reduces protease function.
Purpose of the Study:
- To identify small molecule inhibitors targeting the NS2B-NS3 interaction crucial for DENV replication.
- To characterize the mechanism of action and specificity of identified inhibitors.
Main Methods:
- Structure-based virtual screening of a large compound library against the NS2B/NS3 complex.
- Cell-based viral replication assays to evaluate inhibitor efficacy against DENV.
- In silico analysis and steady-state kinetics to determine the inhibition mechanism.
Main Results:
- A small molecule, SK-12, was identified that inhibits replication across all DENV serotypes (EC50=0.74-4.92 μM).
- SK-12 acts as a noncompetitive inhibitor by occupying the NS2B-binding site on NS3.
- SK-12 showed weaker inhibition against Japanese encephalitis virus, attributed to an amino acid difference in NS3.
Conclusions:
- SK-12 is a promising inhibitor targeting the critical NS2B-NS3 interaction in DENV.
- The findings provide a basis for developing novel antiviral strategies against dengue fever.
- Understanding NS2B/NS3 interaction is key for designing potent DENV inhibitors.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors of Bacterial DNA Synthesis
Leaky Scanning
Inhibitors of Bacterial Protein Synthesis
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...

